Medicinal services and biotech stocks fell pointedly after President-elect Donald Trump assaulted the business amid his public interview Wednesday.
“We need to recover our medication industry coming. Our medication industry has been grievous, they’re leaving left and right. They supply our medications yet they don’t make them here, to a huge degree,” Trump said.
“What’s more, the other thing we need to do is make new offering techniques for the medication business, since they’re escaping with murder,” he said.
Trump went on: “Pharma has a lot of lobbyists and a lot of power, and there is very little bidding. We’re the largest buyer of drugs in the world, and yet we don’t bid properly, and we’re going to save billions of dollars.”
Sarepta Therapeutics Inc: $30.16
Cara Therapeutics Inc: $14.71
Array Biopharma Inc: $11.00